Cat. No. 5176
Chemical Name: 3-[(1S)-1-(3,4-Difluorophenyl)propy
Biological ActivityPotent, noncompetitive human CCR2 antagonist; inhibits MCP-1-induced Ca2+ mobilization in hCCR2-CHO cells (IC50 = 13 nM). Exhibits selectivity for CCR2 over CCR1, CCR3-8 and CXCR1-3. Delays onset and reduces neurological signs in an experimental autoimmune encephalomyelitis model of multiple sclerosis in hCCR2 knock-in mice. Orally active.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Buntinx et al (2008) Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2. J.Pharmacol.Exp.Ther. 327 1. PMID: 18599682.
If you know of a relevant reference for JNJ 27141491 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses JNJ 27141491 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: JNJ 27141491, supplier, JNJ27141491, Tocris Bioscience, Chemokine CC Receptor Antagonist products